Article

Phakic IOL models may induce small amounts of optical aberrations

Lisbon, Portugal - Three widely used anterior chamber phakic IOLs may induce a low degree of optical aberrations in implanted eyes, reported Simonetta Morselli, MD, of the Ophthalmic Unit, Hospital of Verona, Italy.

Lisbon, Portugal - Three widely used anterior chamber phakic IOLs may induce a low degree of optical aberrations in implanted eyes, reported Simonetta Morselli, MD, of the Ophthalmic Unit, Hospital of Verona, Italy.

The overall optical quality of the eyes of patients implanted with AcrySof (Alcon Laboratories), Artisan 204 (Ophtec/AMO), and I-Care (Cornéal) phakic IOLs was good, according to Dr. Morselli.

Twenty-five eyes were included in the study; 20 received either the Artisan IOL or the I-Care IOL and five received the AcrySof IOL. The eyes then were studied with the Topcon KR9000PW topographer/aberrometer. The corneal and ocular aberrations were measured and compared at the 4-mm optical zone, Dr. Morselli explained Monday at the European Society of Cataract and Refractive Surgeons meeting.

There were slight differences among the IOLs in corneal higher-order aberrations, coma, and spherical aberration, but the differences did not reach statistical significance, Dr. Morselli said. The Strehl ratio of each IOL indicated that the patients had good optical quality.

“The anterior chamber IOLs induced a low degree of optical aberrations. The differences among the three lenses did not reach significance. The AcrySof IOL induced less spherical aberration, probably because of the high refractive index of the material. The overall optical quality of the eyes that received the lenses was good,” she said.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
(Image credit: Ophthalmology Times)  ASCRS 2025: Joaquin De Rojas, MD, leverages machine learning model to predict arcuate outcomes
(Image credit: Ophthalmology Times) ASCRS 2025: AnnMarie Hipsley, DPT, PhD, presents VESA for biomechanical simulation of presbyopia progression
Shehzad Batliwala, DO, aka Dr. Shehz, discussed humanitarian ophthalmology and performing refractive surgery in low-resource, high-risk areas at the ASCRS Foundation Symposium.
(Image credit: Ophthalmology Times) ASCRS 2025: Advancing vitreous care with Inder Paul Singh, MD
(Image credit: Ophthalmology Times) The Residency Report: Study provides new insights into USH2A target end points
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
© 2025 MJH Life Sciences

All rights reserved.